Granuloma Annulare in the Setting of Secukinumab
作者： Matthew L. Clark , Courtney A. Tobin , Angela Sutton , Tricia Ann Missall
DOI: 10.1155/2018/5175319
关键词: Etiology 、 Granuloma annulare 、 Interleukin 17 、 Malignancy 、 Secukinumab 、 Dyslipidemia 、 Histiocyte 、 Thyroid disease 、 Dermatology 、 Medicine
摘要: Granuloma annulare (GA) is a common benign inflammatory skin condition classically presenting as skin-colored to erythematous dermal papules and annular plaques. Histologically, GA displays granulomatous infiltrate with palisaded histiocytes surrounding focally altered collagen. The exactly etiology of remains unknown, but it has been associated trauma, various infections, diabetes mellitus, malignancy, thyroid disease, dyslipidemia, several medications. In 2017, case developing in patient treated the interleukin 17A antagonist secukinumab was reported. Here we report second association use.
hindawi.com
core.ac.uk 参考文章(11)
Raluca Niculina Ciurea, Claudia Valentina Georgescu, V Pătraşcu, Claudia Giurcă, Disseminated granuloma annulare: study on eight cases. Romanian Journal of Morphology and Embryology. ,vol. 54, pp. 327- 331 ,(2013)
Alice B Gottlieb, David Rosmarin, Anne LaRaia, Scott Schlauder, Successful treatment of disseminated granuloma annulare with adalimumab. Journal of Drugs in Dermatology. ,vol. 8, pp. 169- ,(2009)
Martin Mempel, Philippe Musette, Beatrice Flageul, Christina Schnopp, Roland Remling, Gabriel Gachelin, Philippe Kourilsky, Johannes Ring, Dietrich Abeck, T-Cell Receptor Repertoire and Cytokine Pattern in Granuloma Annulare: Defining a Particular Type of Cutaneous Granulomatous Inflammation Journal of Investigative Dermatology. ,vol. 118, pp. 957- 966 ,(2002) , 10.1046/J.1523-1747.2002.01783.X
A. Fayyazi, S. Schweyer, B. Eichmeyer, J. Herms, B. Hemmerlein, H. J. Radzun, H. Berger, Expression of IFNγ, coexpression of TNFα and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare Archives of Dermatological Research. ,vol. 292, pp. 384- 390 ,(2000) , 10.1007/S004030000150
M.S. Hertl, I. Haendle, G. Schuler, M. Hertl, Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor‐α inhibitor, infliximab British Journal of Dermatology. ,vol. 152, pp. 552- 555 ,(2005) , 10.1111/J.1365-2133.2005.06371.X
Wesley Wu, Leslie Robinson-Bostom, Efi Kokkotou, Hye-Young Jung, George Kroumpouzos, Dyslipidemia in granuloma annulare: a case-control study. Archives of Dermatology. ,vol. 148, pp. 1131- 1136 ,(2012) , 10.1001/ARCHDERMATOL.2012.1381
Laura A. Thornsberry, Joseph C. English, Etiology, diagnosis, and therapeutic management of granuloma annulare: an update. American Journal of Clinical Dermatology. ,vol. 14, pp. 279- 290 ,(2013) , 10.1007/S40257-013-0029-5
Jesse M. Damsker, Anna M. Hansen, Rachel R. Caspi, Th1 and Th17 cells Annals of the New York Academy of Sciences. ,vol. 1183, pp. 211- 221 ,(2010) , 10.1111/J.1749-6632.2009.05133.X
P V Voulgari, T E Markatseli, S A Exarchou, A Zioga, A A Drosos, Granuloma annulare induced by anti-tumour necrosis factor therapy Annals of the Rheumatic Diseases. ,vol. 67, pp. 567- 570 ,(2007) , 10.1136/ARD.2007.075663
C.L. Nebesio, C. Lewis, T-Y. Chuang, Lack of an association between granuloma annulare and type 2 diabetes mellitus. British Journal of Dermatology. ,vol. 146, pp. 122- 124 ,(2002) , 10.1046/J.0007-0963.2001.04527.X